I agree that Leronlimab may be use with other treatment for CCR5 positive cancers , but Keytruda and other check point inhibitors might be the best with us , especially that side effects are autoimmune disorders and we know that Leronlimab is helping for those diseases .
If the same we will see in combination it will be great for patients, much less side effects.
Honestly when Leronlimab will be approve , I dont see Maraviroc to be use to much , now without competition is use rarely only.
So I think between other combinations with Leronlimab we may even see cure in some cancers ..
The sooner the better and of course we need to see interim results for TNBC.